News & Media

Stay updated with the latest news, press releases, and updates from Amygdala Pharmaceuticals.

Latest News

CERECURA-P Tablets for Cognitive Support & Brain Performance
January 24, 2026

CERECURA-P Tablets for Cognitive Support & Brain Performance

CERECURA-P Tablets combine Citicoline and Piracetam to support memory, focus, attention, and overall cognitive performance.

Read More
BEVRIXA-50 Tablets for Advanced Control of Partial-Onset Seizures
January 24, 2026

BEVRIXA-50 Tablets for Advanced Control of Partial-Onset Seizures

BEVRIXA-50 (Brivaracetam 50 mg) offers rapid and effective control of partial-onset seizures with improved brain penetration.

Read More
VALPROXA ER-500 Tablets for Seizure Control & Mood Stabilization
January 24, 2026

VALPROXA ER-500 Tablets for Seizure Control & Mood Stabilization

VALPROXA ER-500 (Divalproex Sodium ER) provides long-acting control of seizures with added mood-stabilizing benefits.

Read More
PRAZODOC-DSR Capsules for Acidity Control & Digestive Comfort
January 24, 2026

PRAZODOC-DSR Capsules for Acidity Control & Digestive Comfort

PRAZODOC-DSR combines Pantoprazole and Domperidone for effective acid control and improved gastric motility.

Read More
Amygdala Pharmaceutical Pvt. Ltd. Announces Launch of New Therapeutic Product Line
January 12, 2026

Amygdala Pharmaceutical Pvt. Ltd. Announces Launch of New Therapeutic Product Line

Amygdala Pharmaceutical Pvt. Ltd. has introduced a new range of therapeutic products focused on improving patient care and expanding access to essenti...

Read More